You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risk Factors for Neonatal Hyperglycemia Associated With 10% Dextrose Infusion

Carol Louik, ScD; Allen A. Mitchell, MD; Michael F. Epstein, MD; Samuel Shapiro, MD, FRCP(E)

Am J Dis Child. 1985;139(8):783-786.


Abstract

• As part of an intensive drug surveillance program, we identified rates and associated risk factors for hyperglycemia related to intravenous 10% dextrose solution in a population of 1,157 newborns in two neonatal intensive care units. Hyperglycemia related to 10% dextrose solution was observed in 64 exposed infants (5.5%), a rate similar to that observed for hypoglycemia (6.7%) in this population. There was a highly significant trend toward an increasing risk of hyperglycemia with decreasing body weight, such that the risk of hyperglycemia among infants weighing less than 1,000 g was 18 times greater than the risk among infants weighing more than 2,000 g. The risk of hyperglycemia also increased with increasing dextrose dose. The effects of weight and dose were independent. Certain measures of disease severity also were associated with increased risks of hyperglycemia. Because increases in blood glucose levels may affect renal function or possibly lead to intraventricular hemorrhage, it is important that glucose levels in neonates receiving 10% dextrose solution be carefully monitored, and the total dextrose dose be adjusted accordingly.

(AJDC 1985;139:783-786)



Author Affiliations

From the Division of Clinical Pharmacology and Toxicology, Children's Hospital, Boston (Dr Mitchell); the Joint Program in Neonatology, Harvard Medical School, Boston (Dr Epstein); and the Drug Epidemiology Unit, School of Public Health, Boston University School of Medicine (Drs Louik, Mitchell, and Shapiro).


Footnotes

Reprint requests to Pediatric Drug Surveillance Program, Children's Hospital, 300 Long-wood Ave, Boston, MA 02115 (Dr Mitchell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does continuous insulin infusion improve glycaemic control and nutrition in hyperglycaemic very low birth weight infants?
Kairamkonda
Arch. Dis. Child. 2006;91:76-79.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.